Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 202816, 8 pages
http://dx.doi.org/10.1155/2015/202816
Review Article

IFN-γ Priming Effects on the Maintenance of Effector Memory CD4+ T Cells and on Phagocyte Function: Evidences from Infectious Diseases

1Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Avenida Prof. Lineu Prestes 1730, 05508-000 São Paulo, SP, Brazil
2Department of Laboratory Medicine and Pathology, University of Minnesota, 2101 6th Street SE, Room 2-280, Minneapolis, MN 55414, USA

Received 23 April 2015; Accepted 3 September 2015

Academic Editor: Anil Shanker

Copyright © 2015 Henrique Borges da Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. J. Tubo and M. K. Jenkins, “CD4+ T Cells: guardians of the phagosome,” Clinical Microbiology Reviews, vol. 27, no. 2, pp. 200–213, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. T. M. Strutt, K. K. Mckinstry, N. B. Marshall, A. M. Vong, R. W. Dutton, and S. L. Swain, “Multipronged CD4+ T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus,” Immunological Reviews, vol. 255, no. 1, pp. 149–164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. P. Freitas do Rosário, S. M. Muxel, S. M. Rodríguez-Málaga et al., “Gradual decline in malaria-specific memory T cell responses leads to failure to maintain long-term protective immunity to Plasmodium chabaudi AS despite persistence of B cell memory and circulating antibody,” Journal of Immunology, vol. 181, no. 12, pp. 8344–8355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. D. Zens and D. L. Farber, “Memory CD4 T cells in influenza,” in Influenza Pathogenesis and Control—Volume II, vol. 386 of Current Topics in Microbiology and Immunology, pp. 399–421, Springer, Berlin, Germany, 2015. View at Publisher · View at Google Scholar
  5. R. M. Zinkernagel and H. Hengartner, “Protective ‘immunity’ by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory',” Immunological Reviews, vol. 211, pp. 310–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Sallusto, D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia, “Two subsets of memory T lymphocytes with distinct homing potentials and effector functions,” Nature, vol. 401, no. 6754, pp. 708–712, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. S. C. Jameson and D. Masopust, “Diversity in T cell memory: an embarrassment of riches,” Immunity, vol. 31, no. 6, pp. 859–871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. R. Mora and U. H. von Andrian, “T-cell homing specificity and plasticity: new concepts and future challenges,” Trends in Immunology, vol. 27, no. 5, pp. 235–243, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Reinhardt, A. Khoruts, R. Merica, T. Zell, and M. K. Jenkins, “Visualizing the generation of memory CD4 T cells in the whole body,” Nature, vol. 410, no. 6824, pp. 101–105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Pepper and M. K. Jenkins, “Origins of CD4+ effector and central memory T cells,” Nature Immunology, vol. 12, no. 6, pp. 467–471, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Opata and R. Stephens, “Early decision: effector and effector memory T cell differentiation in chronic infection,” Current Immunology Reviews, vol. 9, no. 3, pp. 190–206, 2013. View at Google Scholar · View at Scopus
  12. L. Serghides, T. G. Smith, S. N. Patel, and K. C. Kain, “CD36 and malaria: friends or foes?” Trends in Parasitology, vol. 19, no. 10, pp. 461–469, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. E. Doyle, R. M. O'Connell, G. A. Miranda et al., “Toll-like receptors induce a phagocytic gene program through p38,” Journal of Experimental Medicine, vol. 199, no. 1, pp. 81–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. B. da Silva, É. M. de Salles, R. H. Panatieri et al., “IFN-γ-induced priming maintains long-term strain-transcending immunity against blood-stage Plasmodium chabaudi malaria,” Journal of Immunology, vol. 191, no. 10, pp. 5160–5169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Kalis, M. Gumenscheimer, N. Freudenberg et al., “Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes,” Journal of Immunology, vol. 174, no. 7, pp. 4295–4300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Hu and L. B. Ivashkiv, “Cross-regulation of signaling pathways by IFN-γ: implications for immune responses and autoimmune diseases,” Immunity, vol. 31, no. 4, pp. 539–550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Hu, S. D. Chakravarty, and L. B. Ivashkiv, “Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms,” Immunological Reviews, vol. 226, no. 1, pp. 41–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Macallan, D. Wallace, Y. Zhang et al., “Rapid turnover of effector-memory CD4+ T cells in healthy humans,” Journal of Experimental Medicine, vol. 200, no. 2, pp. 255–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. U. Boehm, T. Klamp, M. Groot, and J. C. Howard, “Cellular responses to interferon-γ,” Annual Review of Immunology, vol. 15, pp. 749–795, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Nansen, J. P. Christensen, O. Marker, and A. R. Thomsen, “Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: role of T cell-dependent production of interferon-γ,” Journal of Infectious Diseases, vol. 176, no. 1, pp. 151–157, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Fejér, K. Szalay, I. Gyory et al., “Adenovirus infection dramatically augments lipopolysaccharide-induced TNF production and sensitizes to lethal shock,” Journal of Immunology, vol. 175, no. 3, pp. 1498–1506, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume, “Interferon-γ: an overview of signals, mechanisms and functions,” Journal of Leukocyte Biology, vol. 75, no. 2, pp. 163–189, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Chen and L. B. Ivashkiv, “IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19438–19443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Bowdridge and W. C. Gause, “Regulation of alternative macrophage activation by chromatin remodeling,” Nature Immunology, vol. 11, no. 10, pp. 879–881, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Wu, Y. Xue, P. Wang et al., “IFN-γ primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b,” Journal of Immunology, vol. 193, no. 6, pp. 3036–3044, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. A. P. F. do Rosário, T. Lamb, P. Spence et al., “IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection,” Journal of Immunology, vol. 188, no. 3, pp. 1178–1190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. A. L. Kurtzhals, V. Adabayeri, B. Q. Goka et al., “Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria,” The Lancet, vol. 351, no. 9118, pp. 1768–1772, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. R. T. Gazzinelli, M. Wysocka, S. Hieny et al., “In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α,” Journal of Immunology, vol. 157, no. 2, pp. 798–805, 1996. View at Google Scholar · View at Scopus
  29. C. A. Hunter, L. A. Ellis-Neyes, T. Slifer et al., “IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi,” The Journal of Immunology, vol. 158, no. 7, pp. 3311–3316, 1997. View at Google Scholar · View at Scopus
  30. J.-H. Gong, M. Zhang, R. L. Modlin et al., “Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression,” Infection and Immunity, vol. 64, no. 3, pp. 913–918, 1996. View at Google Scholar · View at Scopus
  31. K. Nagamatsu, A. Kuwae, T. Konaka et al., “Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN,” The Journal of Experimental Medicine, vol. 206, no. 13, pp. 3073–3088, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Alter, D. Kavanagh, S. Rihn et al., “IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection,” Journal of Clinical Investigation, vol. 120, no. 6, pp. 1905–1913, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. F. Anderson, M. Oukka, V. J. Kuchroo, and D. Sacks, “CD4+CD25Foxp3 Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis,” The Journal of Experimental Medicine, vol. 204, no. 2, pp. 285–297, 2007. View at Publisher · View at Google Scholar
  34. Y. Belkaid, C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks, “CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity,” Nature, vol. 420, no. 6915, pp. 502–507, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. I. J. Suffia, S. K. Reckling, C. A. Piccirillo, R. S. Goldszmid, and Y. Belkaid, “Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens,” Journal of Experimental Medicine, vol. 203, no. 3, pp. 777–788, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. B. B. McCall, M. G. Netea, C. C. Hermsen et al., “Plasmodium falciparum infection causes proinflammatory priming of human TLR responses,” Journal of Immunology, vol. 179, no. 1, pp. 162–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. B. S. Franklin, P. Parroche, M. A. Ataíde et al., “Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5789–5794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. B. S. Franklin, S. O. Rodrigues, L. R. Antonelli et al., “MyD88-dependent activation of dendritic cells and CD4+ T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria,” Microbes and Infection, vol. 9, no. 7, pp. 881–890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Coban, K. J. Ishii, S. Uematsu et al., “Pathological role of Toll-like receptor signaling in cerebral malaria,” International Immunology, vol. 19, no. 1, pp. 67–79, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. B. T. Edelson and E. R. Unanue, “MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity,” The Journal of Immunology, vol. 169, no. 7, pp. 3869–3875, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Muraille, C. De Trez, M. Brait, P. De Baetselier, O. Leo, and Y. Carlier, “Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response,” Journal of Immunology, vol. 170, no. 8, pp. 4237–4241, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. M. G. Netea, B. J. Kullberg, L. E. H. Jacobs et al., “Chlamydia pneumoniae stimulates IFN-γ synthesis through MyD88-dependent, TLR2- and TLR4-independent induction, of IL-18 release,” Journal of Immunology, vol. 173, no. 2, pp. 1477–1482, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Bafica, H. C. Santiago, R. Goldszmid, C. Ropert, R. T. Gazzinelli, and A. Sher, “Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection,” Journal of Immunology, vol. 177, no. 6, pp. 3515–3519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Spörri, N. Joller, U. Albers, H. Hilbi, and A. Oxenius, “MyD88-dependent IFN-γ production by NK cells is key for control of Legionella pneumophila infection,” Journal of Immunology, vol. 176, no. 10, pp. 6162–6171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Parroche, F. N. Lauw, N. Goutagny et al., “Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 6, pp. 1919–1924, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Heremans, J. Van Damme, C. Dillen, R. Dijkmans, and A. Billiau, “IFN-γ, a mediator of lethal lipopolysaccharide-induced shwartzman-like shock reactions in mice,” Journal of Experimental Medicine, vol. 171, no. 6, pp. 1853–1869, 1990. View at Publisher · View at Google Scholar · View at Scopus
  47. A. J. Cunnington, J. B. de Souza, M. Walther, and E. M. Riley, “Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization,” Nature Medicine, vol. 18, no. 1, pp. 120–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. D. W. Gilroy and S. Yona, “HIF1α allows monocytes to take a breather during sepsis,” Immunity, vol. 42, no. 3, pp. 397–399, 2015. View at Publisher · View at Google Scholar
  49. A. Le Bon and D. F. Tough, “Type I interferon as a stimulus for cross-priming,” Cytokine and Growth Factor Reviews, vol. 19, no. 1, pp. 33–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Stockinger, R. Kastner, E. Kernbauer et al., “Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes,” PLoS Pathogens, vol. 5, no. 3, Article ID e1000355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Solodova, J. Jablonska, S. Weiss, and S. Lienenklaus, “Production of IFN-β during listeria monocytogenes infection is restricted to monocyte/macrophage lineage,” PLoS ONE, vol. 6, no. 4, Article ID e18543, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Nakano, M. Yanagita, and M. D. Gunn, “CD11c+B220+Gr-1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells,” The Journal of Experimental Medicine, vol. 194, no. 8, pp. 1171–1178, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Asselin-Paturel, A. Boonstra, M. Dalod et al., “Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology,” Nature Immunology, vol. 2, no. 12, pp. 1144–1150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Crouse, U. Kalinke, and A. Oxenius, “Regulation of antiviral T cell responses by type I interferons,” Nature Reviews Immunology, vol. 15, no. 4, pp. 231–242, 2015. View at Publisher · View at Google Scholar
  55. T. Cavlar, A. Ablasser, and V. Hornung, “Induction of type I IFNs by intracellular DNA-sensing pathways,” Immunology and Cell Biology, vol. 90, no. 5, pp. 474–482, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Matikainen, T. Sareneva, T. Ronni, A. Lehtonen, P. J. Koskinen, and I. Julkunen, “Interferon-α activates multiple STAT proteins and upregulates proliferation-associated IL-2Rα, c-myc, and pim-1 genes in human T cells,” Blood, vol. 93, no. 6, pp. 1980–1991, 1999. View at Google Scholar · View at Scopus
  57. J. P. Huber, S. R. G.-V. Horn, K. T. Roybal, M. A. Gill, and J. D. Farrar, “IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells,” The Journal of Immunology, vol. 192, no. 12, pp. 5687–5694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. L. P. Cousens, J. S. Orange, H. C. Su, and C. A. Biron, “Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 2, pp. 634–639, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. A. A. Byrnes, X. Ma, P. Cuomo et al., “Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity,” European Journal of Immunology, vol. 31, no. 7, pp. 2026–2034, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Le Bon, V. Durand, E. Kamphuis et al., “Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming,” Journal of Immunology, vol. 176, no. 8, pp. 4682–4689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. J. A. Carrero, B. Calderon, and E. R. Unanue, “Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection,” Journal of Experimental Medicine, vol. 200, no. 4, pp. 535–540, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. S. M. Soudja, C. Chandrabos, E. Yakob, M. Veenstra, D. Palliser, and G. Lauvau, “Memory-T-cell-derived interferon-γ instructs potent innate cell activation for protective immunity,” Immunity, vol. 40, no. 6, pp. 974–988, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. D. L. Doolan, C. Dobaño, and J. K. Baird, “Acquired immunity to Malaria,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 13–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Schroder, M. J. Sweet, and D. A. Hume, “Signal integration between IFNγ and TLR signalling pathways in macrophages,” Immunobiology, vol. 211, no. 6–8, pp. 511–524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. R. S. Naik, O. H. Branch, A. S. Woods et al., “Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis,” Journal of Experimental Medicine, vol. 192, no. 11, pp. 1563–1576, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. M. B. Graham, V. L. Braciale, and T. J. Braciale, “Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection,” The Journal of Experimental Medicine, vol. 180, no. 4, pp. 1273–1282, 1994. View at Publisher · View at Google Scholar · View at Scopus
  67. D. M. Brown, A. M. Dilzer, D. L. Meents, and S. L. Swain, “CD4+T cell-mediated protection from lethal influenza: perform and antibody-mediated mechanisms give a one-two punch,” Journal of Immunology, vol. 177, no. 5, pp. 2888–2898, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. D. M. Brown, S. Lee, M. D. L. L. Garcia-Hernandez, and S. L. Swain, “Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection,” Journal of Virology, vol. 86, no. 12, pp. 6792–6803, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. S. L. Swain, K. K. McKinstry, and T. M. Strutt, “Expanding roles for CD4+ T cells in immunity to viruses,” Nature Reviews Immunology, vol. 12, no. 2, pp. 136–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Cheng, H.-W. Wang, A. Cuenca et al., “A critical role for Stat3 signaling in immune tolerance,” Immunity, vol. 19, no. 3, pp. 425–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Saraiva and A. O'Garra, “The regulation of IL-10 production by immune cells,” Nature Reviews Immunology, vol. 10, no. 3, pp. 170–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. G. O. Favorite and H. R. Morgan, “Effects produced by the intravenous injection in man of a toxic antigenic material derived from Eberthella typhosa: clinical, hematological, chemical and serological studies,” Journal of Clinical Investigation, vol. 21, no. 5, pp. 589–599, 1942. View at Publisher · View at Google Scholar
  73. S. I. Miller, R. K. Ernst, and M. W. Bader, “LPS, TLR4 and infectious disease diversity,” Nature Reviews Microbiology, vol. 3, no. 1, pp. 36–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. C. S. Boutlis, T. W. Yeo, and N. M. Anstey, “Malaria tolerance—for whom the cell tolls?” Trends in Parasitology, vol. 22, no. 8, pp. 371–377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Pepper, A. J. Pagán, B. Z. Igyártó, J. J. Taylor, and M. K. Jenkins, “Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells,” Immunity, vol. 35, no. 4, pp. 583–595, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. H. D. Marshall, A. Chandele, Y. W. Jung et al., “Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4+ cell properties during viral infection,” Immunity, vol. 35, no. 4, pp. 633–646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. D. Homann, L. Teyton, and M. B. A. Oldstone, “Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory,” Nature Medicine, vol. 7, no. 8, pp. 913–919, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. R. W. Nelson, J. B. McLachlan, J. R. Kurtz, and M. K. Jenkins, “CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation,” The Journal of Immunology, vol. 190, no. 6, pp. 2828–2834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. W. W. Reiley, S. Shafiani, S. T. Wittmer et al., “Distinct functions of antigen-specific CD4+T cells during murine Mycobacterium tuberculosis infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19408–19413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. D. A. Kaveh, M. Carmen Garcia-Pelayo, and P. J. Hogarth, “Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis,” Vaccine, vol. 32, no. 51, pp. 6911–6918, 2014. View at Publisher · View at Google Scholar
  81. A. J. Pagán, N. C. Peters, A. Debrabant et al., “Tracking antigen-specific CD4+ T cells throughout the course of chronic Leishmania major infection in resistant mice,” European Journal of Immunology, vol. 43, no. 2, pp. 427–438, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. E. Lin, C. C. Kemball, A. Hadley et al., “Heterogeneity among viral antigen-specific CD4+ T cells and their de novo recruitment during persistent polyomavirus infection,” Journal of Immunology, vol. 185, no. 3, pp. 1692–1700, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. C. D. Surh and J. Sprent, “Homeostasis of naive and memory T cells,” Immunity, vol. 29, no. 6, pp. 848–862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Langhorne, F. M. Ndungu, A.-M. Sponaas, and K. Marsh, “Immunity to malaria: more questions than answers,” Nature Immunology, vol. 9, no. 7, pp. 725–732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. K. K. McKinstry, T. M. Strutt, and S. L. Swain, “The potential of CD4 T-cell memory,” Immunology, vol. 130, no. 1, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. J. J. Taylor and M. K. Jenkins, “CD4+ memory T cell survival,” Current Opinion in Immunology, vol. 23, no. 3, pp. 319–323, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. D. M. Catron, L. K. Rusch, J. Hataye, A. A. Itano, and M. K. Jenkins, “CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells,” Journal of Experimental Medicine, vol. 203, no. 4, pp. 1045–1054, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Sarkar, V. Teichgräber, V. Kalia et al., “Strength of stimulus and clonal competition impact the rate of memory CD8+ T cell differentiation,” Journal of Immunology, vol. 179, no. 10, pp. 6704–6714, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Araki, A. P. Turner, V. O. Shaffer et al., “mTOR regulates memory CD8 T-cell differentiation,” Nature, vol. 460, no. 7251, pp. 108–112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. E. L. Pearce, M. C. Walsh, P. J. Cejas et al., “Enhancing CD8 T-cell memory by modulating fatty acid metabolism,” Nature, vol. 460, no. 7251, pp. 103–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. R. J. Johnston, Y. S. Choi, J. A. Diamond, J. A. Yang, and S. Crotty, “STAT5 is a potent negative regulator of TFH cell differentiation,” The Journal of Experimental Medicine, vol. 209, no. 2, pp. 243–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. S.-F. Yu, Y.-N. Zhang, B.-Y. Yang, and C.-Y. Wu, “Human memory, but not naive, CD4+ T cells expressing transcription factor T-bet might drive rapid cytokine,” Journal of Biological Chemistry, vol. 289, no. 51, pp. 35561–35569, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. E. G. Schulz, L. Mariani, A. Radbruch, and T. Höfer, “Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12,” Immunity, vol. 30, no. 5, pp. 673–683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Artavanis-Tsakonas, J. E. Tongren, and E. M. Riley, “The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology,” Clinical and Experimental Immunology, vol. 133, no. 2, pp. 145–152, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. A. O'Garra, P. S. Redford, F. W. McNab, C. I. Bloom, R. J. Wilkinson, and M. P. R. Berry, “The immune response in tuberculosis,” Annual Review of Immunology, vol. 31, pp. 475–527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. C. G. Feng, D. Jankovic, M. Kullberg et al., “Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production,” Journal of Immunology, vol. 174, no. 7, pp. 4185–4192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. B. M. N. Kagina, B. Abel, T. J. Scriba et al., “Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 8, pp. 1073–1079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. N. C. Peters, A. J. Pagán, P. G. Lawyer et al., “Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection,” PLoS Pathogens, vol. 10, no. 12, Article ID e1004538, 2014. View at Publisher · View at Google Scholar · View at Scopus